Meeting commentary-"Parkinson's disease: From patient to product"

John Wahlich, David Elder, Fang Liu, Carmel Hughes, Mine Orlu-Gul

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


A meeting organised by the Academy of Pharmaceutical Sciences (APSGB) Age-Related Medicines Focus Group took place on the 19th of May 2015, in GlaxoSmithKline Ware, UK [∗]. The meeting was the first of a planned series of disease specific meetings organised by APSGB. It was attended by a number of experts involved with the treatment and development of drugs for the older adult, including clinicians, pharmacists, academics, regulators and representatives from industry. The event created the platform to discuss the provision of medicines for the treatment of Parkinson's disease (PD) from a pharmaceutical sciences perspective. 'Medications are something you prescribe: something that gives me my life back' (A PD sufferer).

Original languageEnglish
Article number15078
Pages (from-to)167-171
Number of pages5
JournalInternational Journal of Pharmaceutics
Issue number1
Early online date3 Aug 2015
Publication statusPublished - 15 Oct 2015


  • Dosage form
  • Formulation
  • Medicine
  • Older adult
  • Parkinson's disease


Dive into the research topics of 'Meeting commentary-"Parkinson's disease: From patient to product"'. Together they form a unique fingerprint.

Cite this